Khalid Halahleh

16PUBLICATIONS
175CO-AUTHORS
Regenerative medicine (incl. stem cells)Electroanalytical chemistryHaematologyProcess control and simulationGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|Aug 27, 2026
Impact of Response to Hypomethylating Agent-Based Therapy on Survival Outcomes in the Context of Baseline Clinical-Molecular Risk and Transplant Status in Patients With Higher-Risk Myelodysplastic Syndromes/Neoplasms: An analysis From the International Consortium for MDS (icMDS).

|Aug 11, 2026
Anaphylactic reaction to the second dose of dacarbazine following initial exposure in patient with hodgkin lymphoma.

|Jul 17, 2026
Impact of conditioning regimen on outcomes of young AML patients ( < 40 years) undergoing HCT in complete remission, with transplant conditioning intensity score of 3.5-4.0. A study from the acute leukemia working party of the European Society for Blood and Marrow Transplantation.

|Jul 09, 2026
Point-of-Care Manufacturing of Anti-CD19.1-Chimeric Antigen Receptor-T Cells Using CliniMACS Prodigy: Real-World Experience From Jordan.

|Jun 29, 2026
Outcomes of patients with higher-risk myelodysplastic syndromes/neoplasms treated with hypomethylating agents + venetoclax-an analysis from the International Consortium for MDS (icMDS) VALIDATE database.

|May 29, 2026
Prevalence of PD-L1 Expression in Non-Small Cell Lung Cancer: A Real-World Analysis From Jordan.

Pageof 3

Frequent Collaborators

3 joint publications

Jaime Sanz

3 joint publications

Mahmoud Aljurf

2 joint publications

Luca Castagna

2 joint publications

Didier Blaise